https://crci2na.univ-nantes.fr/medias/photo/marc-billaud-photo_1664543947962-jpg
  • Le 03 mars 2022
    Webinar
    false false

Webinar by Dr. Marc Billaud Co-leader of the Tumor Metabolic Targeting theme in the "Cell Death and Pediatric Cancers", team Director of the Human and Social Sciences Department of the Léon Bernard Center, member of the Expert Committee of the Aviesan Cancer ITMO, Cancer Research Center of Lyon

 Precision oncology, which classically combines the identification of molecular anomalies in tumors and the design of drugs targeting the product of these alterations, is often presented as a therapeutic revolution. However, even if this approach has transformed the prognosis of certain cancers, its development and transfer to clinical routine is confronted with numerous epistemological, medical, economic and social obstacles. The question of the stakes and limits of precision oncology will be the subject of this seminar.